🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 56 of 757 · Phase 3 first, then by program name

  1. Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

    Lxo Ireland Designated Activity Company

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  2. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder (SAD)

    phase 3 small molecule active

    1 trial

  3. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 3 small molecule active

    1 trial

  4. Fasiglifam

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule terminated

    2 trials

  5. Fasiglifam (TAK-875)

    Takeda Pharmaceuticals International AG

    Glycemic Control

    phase 3 small molecule terminated

    1 trial

  6. Fasiglifam (TAK-875)

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus, Type 2

    phase 3 small molecule terminated

    1 trial

  7. Fasinumab

    Regeneron UK Limited

    Low Back Pain

    phase 3 small molecule completed

    1 trial

  8. Fasinumab

    Regeneron UK Limited

    Osteoarthritis of the Knee or Hip

    phase 3 small molecule completed

    1 trial

  9. Fasinumab

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    4 trials

  10. Fasinumab

    Regeneron UK Limited

    Chronic Low Back Pain

    phase 3 small molecule terminated

    1 trial

  11. Fazirsiran Injection

    Takeda Pharmaceuticals International AG

    Alpha1-Antitrypsin Deficiency

    phase 3 small molecule active

    3 trials

  12. Febuxostat

    Takeda Pharmaceuticals International AG

    Cardiovascular Disease

    phase 3 small molecule completed

    1 trial

  13. Febuxostat IR

    Takeda Pharmaceuticals International AG

    Gout

    phase 3 small molecule completed

    2 trials

  14. Femara 2.5 mg film-coated tablets, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Anastrozole 1mg film-coated tablets, Docetaxel Pfizer 10 mg/mL concentrate for solution for infusion, Paclitaxel 6 mg/ml Concentrate for Solution for Infusion, Exemestane 25 mg Film-coated Tablets, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Abraxane 5 mg/ml powder for dispersion for infusion.

    Cancer Prevention Pharma (Ireland) Limited

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 small molecule active

    1 trial

  15. Fentanyl Buccal Tablet

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    1 trial

  16. Fentanyl Buccal Tablets

    Teva Pharma GmbH

    Pain

    phase 3 small molecule terminated

    1 trial

  17. Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    1 trial

  18. Ferric Citrate 1 GM Oral Tablet [AURYXIA]

    Akebia Europe Limited

    Anemia, Iron Deficiency

    phase 3 small molecule completed

    1 trial

  19. Fianlimab

    Regeneron UK Limited

    Melanoma

    phase 3 small molecule active

    3 trials

  20. Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab

    Pharma Mar S.A.

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  21. Fibrinogen (human) + thrombin (human) (TachoSil)

    Takeda Pharmaceuticals International AG

    Surgical Resection of Superficial Renal Tumour

    phase 3 other completed

    1 trial

  22. Ficerafusp alfa

    Bicara Therapeutics

    Metastatic Head and Neck Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  23. Filgotinib

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 3 small molecule completed

    2 trials

  24. Filgotinib

    Lakefront Biotherapeutics NV

    Crohn's Disease

    phase 3 small molecule terminated

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources